Chorioangiomas--new insights into a well-known problem. II. An immuno-histochemical investigation of 136 cases

J Perinat Med. 2003;31(2):170-5. doi: 10.1515/JPM.2003.023.

Abstract

Aims: Chorioangiomas are benign tumors of the hemochorial placenta. They are malformations or hamartomas, formed as a result of defective angiogenesis. They are of clinical importance due to their association with premature placental release and pre-eclampsia.

Methods: Since a link has been established in neoplasias between tumor growth and an increased expression of angiogenic growth factors, 136 samples of chorioangiomas and 136 samples of tumor-free placental tissue were examined in terms of proliferation rate and expression of the growth factors angiopoietin-1 and -2, the angiopoietin-receptor Tie-2, PDGF and the PDFG beta-receptor.

Results: The chorioangiomas exhibited differing proliferation rates, whereas tumor-free placental tissue barely proliferated at all. Angiopoietin expression was--morphologically--considerably higher within the chorioangiomas than in the comparison placentas; morphological amounts of the Tie-2 receptor were identical in all samples. Expression of PDGF and its receptor was the same for chorioangiomas and tumor-free placentas.

Conclusions: According to this study and the current literature in the field of hamartomas and some neoplasia, we can assume that increased growth factor expression plays a role in the formation of chorioangiomas, since it stimulates proliferation in a wide variety of cell compartments.

MeSH terms

  • Angiogenesis Inducing Agents / immunology
  • Female
  • Growth Substances / immunology*
  • Hamartoma / immunology*
  • Hamartoma / pathology
  • Hemangioma / immunology*
  • Hemangioma / pathology
  • Humans
  • Placenta Diseases / immunology*
  • Placenta Diseases / pathology
  • Pregnancy
  • Pregnancy Complications, Neoplastic / immunology*
  • Pregnancy Complications, Neoplastic / pathology

Substances

  • Angiogenesis Inducing Agents
  • Growth Substances